| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8784929 | Advances in Radiation Oncology | 2017 | 14 Pages |
Abstract
Posttreatment SUVmax <6.1 is associated with reduced LR and increased OS after chemoradiation therapy for SCCA independent of T and N stage on multivariate analysis. Greater follow-up is required to confirm this association with late patterns of failure.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Michael L. MD, Christopher R. MD, MS, Stephanie MD, PhD, Todd A. PhD, Thomas R. PhD, Ashley A. MD, Parag J. MD, Jeffrey R. MD,